CALISTOGA PHARMACEUTICALS INC — Form D/A
CALISTOGA PHARMACEUTICALS INC of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2010-12-27. The offering totals $50.0M, of which $25.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-12-27
- Form: D/A
- Accession: 0001385313-10-000004
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $50.0M
- Amount sold: $25.0M
- Remaining: $25.0M
- Investors: 17
- Date of first sale: 2010-06-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-144409
Issuer
- Name: CALISTOGA PHARMACEUTICALS INC
- CIK: 0001385313
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2006
- Address: 2101 FOURTH AVENUE, SEATTLE, WA, 98121
- Phone: (206) 728-4700
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Robert Lee Douglas | Director | The Woodlands, TX |
| Carol Gallagher | Director | Carlsbad, CA |
| W. Michael Gallatin | Director | Seattle, WA |
| Edward Michael Hurwitz | Director | San Francisco, CA |
| Richard Michael Lin | Director | Portola Valley, CA |
| James Michael Topper | Director | Seattle, WA |
| Carol Gallagher | Executive Officer | Carlsbad, CA |
| Andrew Michael Guggenhime | Executive Officer | Seattle, WA |
| Langdon Michael Miller | Executive Officer | Seattle, WA |
| Clifford Michael Stocks | Executive Officer | Seattle, WA |
| W. Michael Gallatin | Promoter | Seattle, WA |
| James Topper | Director | La Jolla, CA |
| James Topper | Executive Officer | La Jolla, CA |
| Ed Hurwitz | Director | San Diego, CA |
| Richard Lin | Director | Portola Valley, CA |
| Aaron Michael Coe | Executive Officer | Seattle, WA |
| Aaron Coe | Executive Officer | Seattle, WA |
| W. Michael Gallatin | Director | Seattle, WA |
| W. Michael Gallatin | Executive Officer | Seattle, WA |
Other filings by this issuer (3)
More